Slenfig 15 mg Capsule 10's
₹107.1*
MRP ₹119
10% off
₹101*
MRP ₹119
15% CB
₹18 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Slenfig 15 mg Capsule 10's belongs to the class of medication called anti-obesity drugs used to treat obesity and help lose weight. Slenfig 15 mg Capsule 10's is recommended for obese patients with an initial body mass index (BMI) ≥ 30 kg/m2 or ≥ 27 kg/m2 in the presence of other risk factors (e.g., dyslipidemia or Abnormally elevated cholesterol or fats, diabetes, controlled hypertension). Slenfig 15 mg Capsule 10's should be used along with a low-calorie diet and regular physical exercise. Obesity is a medical condition caused by excess body fat, making a person overweight and predisposing them to many conditions and disorders. Intake of more calories than you burn by exercise or daily activities results in obesity.
Slenfig 15 mg Capsule 10's contains Sibutramine which causes weight loss by suppressing the appetite and promoting energy expenditure.
Take Slenfig 15 mg Capsule 10's as prescribed by your doctor. You are advised to take Slenfig 15 mg Capsule 10's for as long as your doctor has prescribed it for you based on your condition. Some people may experience dry mouth, headache, loss of appetite, trouble sleeping, and constipation. Most of these side effects of Slenfig 15 mg Capsule 10's do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
Slenfig 15 mg Capsule 10's is contraindicated in patients with hypersensitivity to Sibutramine or any of the inactive ingredients in it. Slenfig 15 mg Capsule 10's is contraindicated in patients receiving monoamine oxidase inhibitors (MAOIs) or other centrally acting weight loss drugs. It is recommended not to use in patients with a major eating disorder (anorexia nervosa or bulimia nervosa). The use of Slenfig 15 mg Capsule 10's during pregnancy and breastfeeding is not recommended. The efficacy of Sibutramine in adolescents who are obese has not been adequately studied. The concomitant use of Slenfig 15 mg Capsule 10's and excess alcohol is not recommended.
Slenfig 15 mg Capsule 10's contains Sibutramine, an anti-obesity drug indicated for managing obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a reduced-calorie diet. Slenfig 15 mg Capsule 10's is recommended for obese patients with an initial body mass index (BMI) ≥ 30 kg/m2 or ≥ 27 kg/m2 in the presence of other risk factors (e.g., dyslipidemia or Abnormally elevated cholesterol or fats, diabetes, controlled hypertension). Sibutramine causes weight loss by suppressing the appetite and by promoting energy expenditure. Slenfig 15 mg Capsule 10's should be used along with a low-calorie diet and regular physical exercise. Thus, Slenfig 15 mg Capsule 10's promotes weight loss and lowers the possibility of developing major health issues.
If you have an allergy to any ingredient in Slenfig 15 mg Capsule 10's, it is advised that you avoid using it. While taking Slenfig 15 mg Capsule 10's, women who are sexually active should use effective contraception. Patients should be instructed to inform their doctor immediately if they get pregnant or plan to get pregnant while taking Slenfig 15 mg Capsule 10's. Sibutramine or its metabolites may be excreted in human milk; however, this is unknown. Therefore, using Slenfig 15 mg Capsule 10's while breastfeeding is not advised. Since there is little knowledge on utilizing Slenfig 15 mg Capsule 10's in teens, it is advised against doing so. Inform your doctor about your medical history and the other drugs you are currently taking before taking Slenfig 15 mg Capsule 10's to rule out any possible side effects or interactions.
Drug-Drug Interactions: Slenfig 15 mg Capsule 10's may interact with monoamine oxidase inhibitors or antidepressants (e.g. isocarboxazid, phenelzine, citalopram, clomipramine, doxepin), medicines used to prevent nausea and vomiting in certain conditions (e.g. ondansetron), medicines used to treat the symptoms of migraine headaches (e.g. sumatriptan) and other centrally acting weight loss drugs (e.g. merastin).
Drug-Food Interactions: Avoid high-fat meals and alcoholic beverages.
Drug-Disease Interactions: Slenfig 15 mg Capsule 10's may interact with disease conditions, including anorexia nervosa (An eating disorder), cardiovascular disorders, glaucoma (eye conditions that can cause blindness) and renal/liver disease.
Obesity: Obesity is a common condition associated with excessive body fat, which in turn increases the risk of other health problems such as diabetes, high blood pressure, certain cancers and heart disease. Intake of more calories than you burn by exercise or daily activities results in obesity. Some common causes of obesity include insufficient sleep, growing older, pregnancy, genetics, hypothyroidism (underactive thyroid gland) or polycystic ovary syndrome (imbalance of female reproductive hormones). Proper diet and exercise are advised, along with medication to treat obesity.
Country of origin
Alcohol
Caution
Do not consume alcohol while on treatment with Slenfig 15 mg Capsule 10's as it may cause serious side effects.
Pregnancy
Caution
No adequate and well-controlled studies with Slenfig 15 mg Capsule 10's have been conducted on pregnant women. So, the use of Slenfig 15 mg Capsule 10's during pregnancy is not recommended.
Breast Feeding
Caution
It is unknown whether sibutramine is excreted in human milk. Therefore, Slenfig 15 mg Capsule 10's is not recommended for use in nursing mothers.
Driving
Safe if prescribed
It is not known whether Slenfig 15 mg Capsule 10's alters the ability to drive. Do not drive or operate machinery if you experience symptoms affecting your ability to concentrate and react. Seek medical attention if the symptoms persist longer.
Liver
Caution
Patients with severe hepatic dysfunction have not been systematically studied; Slenfig 15 mg Capsule 10's should not be used in such patients.
Kidney
Caution
Patients with mild to severe renal impairment should use Slenfig 15 mg Capsule 10's with caution. Patients with severe renal impairment, such as those receiving dialysis for end-stage renal disease, should not utilize Slenfig 15 mg Capsule 10's.
Children
Unsafe
It is unknown if sibutramine is safe and effective for use in pediatric patients under the age of 16.
We provide you with authentic, trustworthy and relevant information